Published in Hepatology on February 01, 1994
Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis. Am J Pathol (1999) 1.58
Reduced liver fibrosis in hypoxia-inducible factor-1alpha-deficient mice. Am J Physiol Gastrointest Liver Physiol (2009) 1.52
Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing. J Clin Invest (1996) 1.38
Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia. Am J Pathol (1998) 1.28
Cholangiocyte endothelin 1 and transforming growth factor beta1 production in rat experimental hepatopulmonary syndrome. Gastroenterology (2005) 1.05
Effects of quercetin on liver damage in rats with carbon tetrachloride-induced cirrhosis. Dig Dis Sci (2003) 1.05
Hepatic artery and portal vein remodeling in rat liver: vascular response to selective cholangiocyte proliferation. Am J Pathol (2003) 1.04
Molecular pathogenesis of cholangiocarcinoma. Int J Hepatol (2011) 1.02
Paclitaxel interrupts TGF-beta1 signaling between gallbladder epithelial cells and myofibroblasts. J Surg Res (2007) 0.93
Regulation and function of trefoil factor family 3 expression in the biliary tree. Am J Pathol (2004) 0.90
Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotides. J Drug Target (2012) 0.89
Effect of transforming growth factor-beta1 on human intrahepatic cholangiocarcinoma cell growth. World J Gastroenterol (2006) 0.86
Molecular mechanisms of cholangiocarcinoma. World J Gastrointest Pathophysiol (2010) 0.82
Lipopolysaccharide enhances transforming growth factor β1-induced platelet-derived growth factor-B expression in bile duct epithelial cells. J Gastroenterol Hepatol (2012) 0.77
Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc (1991) 12.74
Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med (1991) 7.21
Mechanisms of major biliary injury during laparoscopic cholecystectomy. Ann Surg (1992) 4.12
Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys (1995) 3.20
Novel imprinted DLK1/GTL2 domain on human chromosome 14 contains motifs that mimic those implicated in IGF2/H19 regulation. Genome Res (2000) 2.73
The measured electrical properties of normal and malignant human tissues from 50 to 900 MHz. Med Phys (1994) 2.32
Genomic imprinting: implications for human disease. Am J Pathol (1999) 2.26
Long-term outcome of early steroid withdrawal after kidney transplantation in African American recipients monitored by surveillance biopsy. Am J Transplant (2008) 2.21
Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet (1997) 2.20
In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention. Cancer Res (2000) 2.06
Laparoscopic surgery and the systemic immune response. Ann Surg (1998) 1.99
Hepatic abscess. Changes in etiology, diagnosis, and management. Ann Surg (1990) 1.98
Abdominal musculature abnormalities as a cause of groin pain in athletes. Inguinal hernias and pubalgia. Am J Sports Med (1991) 1.88
Liver regeneration studies with rat hepatocytes in primary culture. Cancer Res (1982) 1.81
M6P/IGF2R imprinting evolution in mammals. Mol Cell (2000) 1.77
M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet (1995) 1.77
Brief report: treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation. N Engl J Med (1994) 1.77
Pylorus-preserving pancreatoduodenectomy. A clinical and physiologic appraisal. Ann Surg (1986) 1.74
Experimental models of traumatic brain injury: do we really need to build a better mousetrap? Neuroscience (2005) 1.71
Cholelithoptysis and cholelithorrhea: rare complications of laparoscopic cholecystectomy. Gastroenterology (1993) 1.71
Complications of laparoscopic cholecystectomy. Am J Surg (1993) 1.70
Plasma transforming growth factor beta1 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys (1998) 1.65
Light and brassinosteroid signals are integrated via a dark-induced small G protein in etiolated seedling growth. Cell (2001) 1.61
N-(4-Hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat. Cancer Res (1979) 1.56
Quality of life after treatment for pancreatitis. Ann Surg (1996) 1.53
Toothbrush swallowing. Arch Surg (1988) 1.49
CT arterial portography: causes of technical failure and variable liver enhancement. AJR Am J Roentgenol (1992) 1.48
Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl J Med (1993) 1.45
Meta-analysis of randomized controlled trials on the safety and effectiveness of day-case laparoscopic cholecystectomy. Br J Surg (2008) 1.40
Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor. Ann Surg (1995) 1.40
Reimbursement for acute care nurse practitioner services. Am J Crit Care (2000) 1.40
The use of a chelating resin column for preconcentration of trace elements from sea-water in their determination by neutron-activation analysis. Talanta (1977) 1.39
Bone morphogenetic protein-9 binds to liver cells and stimulates proliferation. Endocrinology (1995) 1.38
Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta. Int J Radiat Oncol Biol Phys (2001) 1.38
Liver metastases from breast cancer: long-term survival after curative resection. Surgery (2000) 1.38
Adenocarcinoma of the stomach. Changing patterns over the last 4 decades. Ann Surg (1987) 1.36
Hepatocellular carcinoma. Br J Surg (1998) 1.35
Detection of a pancreatic cancer-associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma. Proc Natl Acad Sci U S A (1984) 1.33
Divergent evolution in M6P/IGF2R imprinting from the Jurassic to the Quaternary. Hum Mol Genet (2001) 1.32
A comparison of the histopathology of premalignant and malignant mammary gland lesions induced in sexually immature rats with those occurring in the human. Lab Invest (2000) 1.32
M6P/IGF2 receptor: a candidate breast tumor suppressor gene. Oncogene (1996) 1.31
Gastric adenocarcinoma: CT versus surgical staging. Radiology (1988) 1.30
Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis. Proc Natl Acad Sci U S A (1997) 1.29
Monotreme IGF2 expression and ancestral origin of genomic imprinting. J Exp Zool (2001) 1.28
Adenosine nucleotides in bile. Am J Physiol (1996) 1.28
Does vasectomy accelerate testicular tumour? Importance of testicular examinations before and after vasectomy. BMJ (1990) 1.28
Laparoscopic Nissen fundoplication: operative results and short-term follow-up. Am J Surg (1994) 1.27
Transforming growth factor-beta 1 expression in irradiated liver. Radiat Res (1990) 1.27
Hand-assisted laparoscopic surgery (HALS) with the HandPort system: initial experience with 68 patients. Ann Surg (2000) 1.27
Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rat. Cancer Res (1994) 1.25
Injury to aberrant bile ducts during cholecystectomy: a common cause of diagnostic error and treatment delay. AJR Am J Roentgenol (1999) 1.25
The neuronatin gene resides in a "micro-imprinted" domain on human chromosome 20q11.2. Genomics (2001) 1.24
Continuing evolution in the approach to severe liver trauma. Ann Surg (1992) 1.23
Plasma transforming growth factor-beta1 level before radiotherapy correlates with long term outcome of patients with lung carcinoma. Cancer (1999) 1.23
Surgical resection for benign and malignant liver disease. Ann Surg (1980) 1.22
Transplantation system for determining the clonogenic survival of parenchymal hepatocytes exposed to ionizing radiation. Cancer Res (1981) 1.22
Imprinted genes in liver carcinogenesis. FASEB J (1997) 1.22
Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors. Oncogene (1995) 1.22
Bacterial infection promotes DNA hypermethylation. J Dent Res (2007) 1.22
Hepatic resection for metastatic cancer. Ann Surg (1984) 1.21
Mechanisms of gastric and esophageal perforations during laparoscopic Nissen fundoplication. Ann Surg (1996) 1.21
Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor (M6P/IGF2R) locus predisposes patients to radiation-induced lung injury. Int J Radiat Oncol Biol Phys (2001) 1.21
Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis. Int J Radiat Oncol Biol Phys (1997) 1.20
Changes in plasma TGF beta levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis. Int J Radiat Oncol Biol Phys (1994) 1.19
Theoretical and measured electric field distributions within an annular phased array: consideration of source antennas. IEEE Trans Biomed Eng (1993) 1.17
Self-help activities in cocaine dependent patients entering treatment: results from NIDA collaborative cocaine treatment study. Drug Alcohol Depend (1996) 1.17
Transforming growth factor-beta 1 as a signal for induction of cell death by apoptosis. Br J Cancer (1993) 1.16
Epigenetic detection of human chromosome 14 uniparental disomy. Hum Mutat (2003) 1.15
The management of tumors of the ampulla of Vater by local resection. Ann Surg (1996) 1.14
M6P/IGF2R is mutated in squamous cell carcinoma of the lung. Oncogene (2000) 1.14
Triphenylselenonium and diphenylselenide in cancer chemoprevention: comparative studies of anticarcinogenic efficacy, tissue selenium levels and excretion profile. Anticancer Res (1998) 1.13
Aortic and arterial aneurysms in behçet disease: management with stent-grafts--initial experience. Radiology (2001) 1.13
Isolation, culture, and transplantation of human hepatocytes. J Natl Cancer Inst (1982) 1.12
Conjugated linoleic acid-enriched butter fat alters mammary gland morphogenesis and reduces cancer risk in rats. J Nutr (1999) 1.12
Marsupials and Eutherians reunited: genetic evidence for the Theria hypothesis of mammalian evolution. Mamm Genome (2001) 1.09
Prospective study of hepatobiliary scintigraphy and endoscopic cholangiography for the detection of early biliary complications after orthotopic liver transplantation. Br J Surg (1997) 1.08
Effect of caloric restriction on pre-malignant and malignant stages of mammary carcinogenesis. Carcinogenesis (1997) 1.08
Associations between antibiotic exposure during pregnancy, birth weight and aberrant methylation at imprinted genes among offspring. Int J Obes (Lond) (2013) 1.05
Plasma transforming growth factor-beta 1 reflects disease status in patients with lung cancer after radiotherapy: a possible tumor marker. Lung Cancer (1996) 1.04
Delayed inhibition of Nogo-A does not alter injury-induced axonal sprouting but enhances recovery of cognitive function following experimental traumatic brain injury in rats. Neuroscience (2005) 1.04
Hepatic adenoma: MR characteristics and correlation with pathologic findings. AJR Am J Roentgenol (1994) 1.04
Early prediction of initiation of abstinence from cocaine. Use of a craving questionnaire. Am J Addict (1997) 1.03
Insulin and counterregulatory hormones influence acute-phase protein production in human hepatocytes. Am J Physiol (1995) 1.03
Morphologic and histochemical analysis of hepatocytes transplanted into syngeneic hosts. Am J Pathol (1980) 1.03
Bile flow--an index of ischemic injury. J Surg Res (1987) 1.02
Dietary vanadyl(IV) sulfate inhibits chemically-induced mammary carcinogenesis. Carcinogenesis (1984) 1.02
Differential induction of growth arrest inducible genes by selenium compounds. Biochem Pharmacol (1997) 1.01
Energy availability and mammary carcinogenesis: effects of calorie restriction and exercise. Carcinogenesis (1997) 1.01
Selenium modulation of cell proliferation and cell cycle biomarkers in normal and premalignant cells of the rat mammary gland. Cancer Epidemiol Biomarkers Prev (2000) 1.01
The relevance of transforming growth factor beta 1 in pulmonary injury after radiation therapy. Lung Cancer (1998) 1.01
Disruption of ligand binding to the insulin-like growth factor II/mannose 6-phosphate receptor by cancer-associated missense mutations. J Biol Chem (1999) 1.01
Using plasma transforming growth factor beta-1 during radiotherapy to select patients for dose escalation. J Clin Oncol (2001) 1.00
The G protein beta subunit Gpb1 of Schizosaccharomyces pombe is a negative regulator of sexual development. Mol Gen Genet (1996) 1.00
Gene expression changes associated with chemically induced rat mammary carcinogenesis. Mol Carcinog (1997) 1.00
Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma. Ann Surg (1995) 1.00
The technique of laparoscopic cholecystectomy in children. Ann Surg (1992) 0.99
Diagnosis and surgical treatment of colonic endometriosis. Arch Surg (1979) 0.99
Effect of verapamil on malignant tissue blood flow in SMT-2A tumor-bearing rats. Cancer Res (1982) 0.99
Imprinted M6p/Igf2 receptor is mutated in rat liver tumors. Oncogene (1998) 0.99